Cargando…

Study of Hepatitis C Virus Detection Assays

BACKGROUND: Hepatitis C virus is a small, enveloped, positive-sense single-stranded RNA virus that causes and liver cancer like hepatocellular carcinoma and lymphomas. Aim of the study: to assess different methods in diagnosis HCV infection. PATIENTS AND METHODS: A retrospective study of 426 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Khudur Al-Nassary, Mithaq Sabeeh, Mahdi, Batool Mutar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202795/
https://www.ncbi.nlm.nih.gov/pubmed/30377525
http://dx.doi.org/10.1016/j.amsu.2018.10.002
_version_ 1783365755831582720
author Khudur Al-Nassary, Mithaq Sabeeh
Mahdi, Batool Mutar
author_facet Khudur Al-Nassary, Mithaq Sabeeh
Mahdi, Batool Mutar
author_sort Khudur Al-Nassary, Mithaq Sabeeh
collection PubMed
description BACKGROUND: Hepatitis C virus is a small, enveloped, positive-sense single-stranded RNA virus that causes and liver cancer like hepatocellular carcinoma and lymphomas. Aim of the study: to assess different methods in diagnosis HCV infection. PATIENTS AND METHODS: A retrospective study of 426 patients was admitted to Al-Kindy Teaching Hospital, Baghdad-Iraq for surgical operations or renal dialysis from January-2015 to December-2016. Their serum tested for HCV Abs by rapid immunochromatography, Enzyme Linked ImunoSorbent Assay (ELISA), and RIBA test. RESULTS: The study sample was 426 patients, their age was ranged from 15 to 65 years. Males were represented 58% and the rest were females. The serum of all samples has tested by rapid Immunochromatography test. Fifty percent of them showed positive results by this test and the rest were negative. Those fifty serum samples who were positive by Immunochromatography test were reexamined by ELISA test and showed 39out of 50 (78%) were true positive by ELISA test and the rest were negative (P = 0.0001). The positive samples by ELISA have tested by RIBA test that showed 200(80%)were true positive in males and 130(74%)were true positive in females and the rest were false positive (P = 0.0001). CONCLUSIONS: Early screening of the high risk group of population by highly sensitive test is important to treat infected patients and prevent dissemination among population.
format Online
Article
Text
id pubmed-6202795
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62027952018-10-30 Study of Hepatitis C Virus Detection Assays Khudur Al-Nassary, Mithaq Sabeeh Mahdi, Batool Mutar Ann Med Surg (Lond) Original Research BACKGROUND: Hepatitis C virus is a small, enveloped, positive-sense single-stranded RNA virus that causes and liver cancer like hepatocellular carcinoma and lymphomas. Aim of the study: to assess different methods in diagnosis HCV infection. PATIENTS AND METHODS: A retrospective study of 426 patients was admitted to Al-Kindy Teaching Hospital, Baghdad-Iraq for surgical operations or renal dialysis from January-2015 to December-2016. Their serum tested for HCV Abs by rapid immunochromatography, Enzyme Linked ImunoSorbent Assay (ELISA), and RIBA test. RESULTS: The study sample was 426 patients, their age was ranged from 15 to 65 years. Males were represented 58% and the rest were females. The serum of all samples has tested by rapid Immunochromatography test. Fifty percent of them showed positive results by this test and the rest were negative. Those fifty serum samples who were positive by Immunochromatography test were reexamined by ELISA test and showed 39out of 50 (78%) were true positive by ELISA test and the rest were negative (P = 0.0001). The positive samples by ELISA have tested by RIBA test that showed 200(80%)were true positive in males and 130(74%)were true positive in females and the rest were false positive (P = 0.0001). CONCLUSIONS: Early screening of the high risk group of population by highly sensitive test is important to treat infected patients and prevent dissemination among population. Elsevier 2018-10-06 /pmc/articles/PMC6202795/ /pubmed/30377525 http://dx.doi.org/10.1016/j.amsu.2018.10.002 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
Khudur Al-Nassary, Mithaq Sabeeh
Mahdi, Batool Mutar
Study of Hepatitis C Virus Detection Assays
title Study of Hepatitis C Virus Detection Assays
title_full Study of Hepatitis C Virus Detection Assays
title_fullStr Study of Hepatitis C Virus Detection Assays
title_full_unstemmed Study of Hepatitis C Virus Detection Assays
title_short Study of Hepatitis C Virus Detection Assays
title_sort study of hepatitis c virus detection assays
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202795/
https://www.ncbi.nlm.nih.gov/pubmed/30377525
http://dx.doi.org/10.1016/j.amsu.2018.10.002
work_keys_str_mv AT khuduralnassarymithaqsabeeh studyofhepatitiscvirusdetectionassays
AT mahdibatoolmutar studyofhepatitiscvirusdetectionassays